| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00054 | 1 |